Stroke study: Exotendon assistance vs End-effector assistance
Official title Assistance Delivery and Muscle Coordination
ClinicalTrials.gov ID: NCT07011173
What this study is testing
- What it's testing
- The experiment will be conducted with 15 chronic stroke survivors and 15 control people.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 80. Healthy volunteers may be eligible.
You may be able to join if
- Age: 18 - 70 years old
- First-ever unilateral cortical stroke with resultant hemiparesis at least 6 months prior to the experimental testing
- Fugl-Meyer Upper Extremity Section 31 - 55
You likely can't join if
- Presence of concurrent severe medical illness
- Pain in hand or arm with movements
- Loss of voluntary control of fingers and thumb
- Inability to provide informed consent
- Musculoskeletal injuries (e.g., fracture) or medical complications (e.g., severe cardiovascular disease).
The study team makes the final eligibility decision.
Where it is enrolling
- Washington D.C., District of Columbia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 80 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Washington D.C., District of Columbia, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.